Alexey
Strygin

10+ years in longevity biotech, including executive roles at Gero and Insilico Medicine. I build companies around breakthrough science from early-stage discovery to fundraising. Deep in the longevity ecosystem. I know who's building, who's funding, and what's next.

• Conducted "How Billionaires Die" research (500K+ views across platforms)
• Led a GLP-1 biotech as CEO starting in 2017, years before the GLP-1 wave
• Co-organized Agentic AI Against Aging hackathon (~1,000 registered)
• Secured critical funding for Insilico Medicine and Gero at pivotal moments
• Connected founders with capital and LPs with funds, including a $5M deal
• Co-organized longevity-focused popup cities (Zelar City in Berlin, Viva Frontier Tower in San Francisco)
• Co-built a biomedical cluster in a special economic zone
• Created an Entrepreneurship in Biotech MSc course, taught 10+ generations of students
• Spoke at CogX (London), Longevity Summit Dublin, Longevity Nation (Tel Aviv), Insurtech Insights (Hong Kong), Interventions in Aging and multiple other conferences and podcasts